Geode Capital Management, LLC Immuneering Corp Transaction History
Geode Capital Management, LLC
- $1.24 Trillion
- Q1 2025
A detailed history of Geode Capital Management, LLC transactions in Immuneering Corp stock. As of the latest transaction made, Geode Capital Management, LLC holds 225,817 shares of IMRX stock, worth $564,542. This represents 0.0% of its overall portfolio holdings.
Number of Shares
225,817
Previous 208,387
8.36%
Holding current value
$564,542
Previous $458,000
25.11%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding IMRX
# of Institutions
37Shares Held
4.78MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.06MShares$2.64 Million0.0% of portfolio
-
Marshall Wace, LLP London, X0808KShares$2.02 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD659KShares$1.65 Million0.0% of portfolio
-
Black Rock Inc. New York, NY533KShares$1.33 Million0.0% of portfolio
-
Morgan Stanley New York, NY467KShares$1.17 Million0.0% of portfolio
About Immuneering Corp
- Ticker IMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,392,300
- Market Cap $66M
- Description
- Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...